Lambert-Eaton myasthenic syndrome

Fampridine has been used clinically in Lambert-Eaton myasthenic syndrome and multiple sclerosis.

A different condition, Lambert-Eaton myasthenic syndrome, is usually associated with presynaptic antibodies to the voltage-dependent calcium channel.

Beryl Wayne Sprinkel, 85, American economist, Lambert-Eaton myasthenic syndrome.

The principal autoimmune diseases studied are myasthenia gravis, the Lambert-Eaton myasthenic syndrome and acquired neuromyotonia.

Edrophonium (by the so-called Tensilon test) is used to differentiate myasthenia gravis from cholinergic crisis and Lambert-Eaton myasthenic syndrome.

He ran a clinic for neurological paraneoplastic syndromes, myasthenia gravis, neuromyotonia, Lambert-Eaton myasthenic syndrome, and autoimmune encephalitis.

Lambert-Eaton myasthenic syndrome is a disorder where presynaptic calcium channels are subjected to autoimmune destruction which causes fewer neurotransmitter vesicles to be exocytosed.

Lambert-Eaton myasthenic syndrome (LEMS) is a well-known paraneoplastic condition linked to small-cell carcinoma.

Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder that affects the presynaptic portion of the neuromuscular junction.

Lambert-Eaton myasthenic syndrome (LEMS), is similar to myasthenia gravis in that it is an autoimmune disease.

Sprinkel died on August 22, 2009, aged 85, from Lambert-Eaton myasthenic syndrome in a nursing and rehabilitation center in Beecher, Illinois.

In addition, because of their neuroendocrine cell origin, small-cell carcinomas will often secrete substances that result in paraneoplastic syndromes such as Lambert-Eaton myasthenic syndrome.

Approximately half of all individuals diagnosed with Lambert-Eaton myasthenic syndrome (LEMS) will eventually be found to have a small-cell carcinoma of the lung.

It is the cancer most commonly associated with paraneoplastic syndromes, including the syndrome of inappropriate antidiuretic hormone secretion, paraneoplastic cerebellar degeneration, and Lambert-Eaton myasthenic syndrome.

In lung cancer, these phenomena may include Lambert-Eaton myasthenic syndrome (muscle weakness due to autoantibodies), hypercalcemia, or syndrome of inappropriate antidiuretic hormone (SIADH).

'Lambert-Eaton myasthenic syndrome' (LEMS) is a rare autoimmune disorder which affects voltage-gated calcium channels on the pre-synaptic membrane of the nerve-muscle (neuromuscular junction) junction.

Lambert-Eaton myasthenic syndrome (LEMS Lambert-Eaton syndrome or Eaton-Lambert syndrome) is a rare autoimmune disorder that is characterised by muscle weakness of the limbs.

Diseases of the motor end plate include myasthenia gravis, a form of muscle weakness due to antibodies to the acetylcholine receptor, and its related condition Lambert-Eaton myasthenic syndrome (LEMS).

However, autoreactive antibodies can be detected in a variety of peripheral (e.g. myasthenia gravis, Lambert-Eaton myasthenic syndrome) and central nervous system (e.g. paraneoplastic cerebellar degeneration, paraneoplastic limbic encephalitis) disorders.

In 2010, BioMarin was granted marketing approval by the European Commission for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate for the treatment of the rare autoimmune disease Lambert-Eaton myasthenic syndrome (LEMS).

The haplotype is positively associated with coeliac disease, dermatitis herpetiformis, juvenile diabetes, Lambert-Eaton myasthenic syndrome (LEMS), Sjögren's syndrome, and autoimmune hepatitis (although significant proportion of the risk is secondary to coeliac disease).